Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
Investing.com -- Galderma Group AG (SIX:GALD) announced Tuesday that Chief Financial Officer Thomas Dittrich will leave the company to pursue another senior executive role outside the organization.
Dittrich will remain with the dermatology company through the second quarter of 2026 to ensure a smooth transition through the close of the 2025 fiscal year.
Galderma plans to announce a successor in due course.
Flemming Ørnskov, Chief Executive Officer of Galderma, acknowledged Dittrich’s contributions to the company, stating: "We thank Thomas for his financial leadership and many contributions during his time at Galderma.
"He played a key role in establishing the financial discipline, operational readiness, and strategic clarity that will continue to guide us forward."
Dittrich expressed gratitude to the company leadership and colleagues, calling his time at Galderma "the most impactful transformation and growth journey of my career."
Galderma, which describes itself as the pure-play dermatology category leader, operates in approximately 90 countries.
The company offers products and services across Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology markets. Founded in 1981, Galderma focuses exclusively on skin-related healthcare solutions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.